Font Size: a A A

Clinical Study On Asthenospermia Of Using Moxibustion Treatment Of Kidney Yang Deficiency Type Based On The Theory Of Benefiting The Governor And Regulating Yin And Yang

Posted on:2019-12-31Degree:MasterType:Thesis
Country:ChinaCandidate:K TanFull Text:PDF
GTID:2394330566494913Subject:Chinese medicine surgery
Abstract/Summary:PDF Full Text Request
Objectives: To explore the clinical efficacy of moxibustion in the treatment of kidney yang-deficiency asthenospermia.It provides a new simple,safe,and effective treatment method for clinical treatment of the disease and lays a theoretical foundation for the clinical promotion of moxibustion in asthenospermia.Method: We collected patients with asthenospermia who were diagnosed as having kidney yang deficiency in the male outpatient department of the Affiliated Hospital of Chengdu University of Traditional Chinese Medicine from March 2017 to March 2018.In a randomized controlled trial,80 cases of asthenospermia patients who met the inclusion criteria were divided into two groups: the experimental group(Qiangjing Tablet + moxibustion group)and the control group(Qiangjing Tablet),40 cases in each group.Before and after sperm movement percentage,survival rate and kidney yang deficiency TCM syndrome score changes.The results were statistically analyzed using SPSS22.0 software.The difference was statistically significant at P<0.05.Results: 1.Baseline information: In the experimental group,the average age of the 36 patients was(31.89±0.67)years old,the youngest was 25 years old,and the maximum was 42 years;the control group 39 patients had an average age(30.85±0.48)years old,the youngest was 24 years old,and the oldest was 36 years old.The ages of the experimental group and the control group were statistically analyzed.The age difference between the two groups was not statistically significant(P>0.05),so it was comparable.The average duration of disease in the experimental group was(3.06±0.24)years,the longest was 8 years,and the shortest was 1 year;the average duration of disease in the control group was(2.79±0.16)years,the longest was 6 years,and the shortest was 1 year.By analyzing the average course of disease in the test group and the control group,the average course of the disease between the two groups was not statistically significant(P>0.05),so it was comparable.2.Shedding This study included 80 patients,divided into experimental group and control group of 40 cases each.In the experimental process,the experimental group was detached in 4 cases,and the control group was detached in 1 case.All of them were lost due to loss of follow-up.All 5 cases were recorded before treatment and were not recorded after treatment.Therefore,they were not included in the efficacy evaluation.Finally,the experimental group completed 36 cases.The control group completed 39 cases.3.Clinical efficacy 3.1 The average PR before treatment in the experimental group was 16.64±6.51%,and the average PR after treatment was 24.03±9.35%.The difference in PR before and after treatment was statistically significant(P<0.01);the average PR before treatment in the experimental group was 3.1.+NP(35.92±11.68)%,PR+NP(44.09±13.44)% after treatment,PR+NP difference before and after treatment had significant statistical significance(P<0.01).3.2 The average PR before treatment in the control group was 16.97±7.88%,and the average PR after treatment was 22.00±12.11%.The PR difference before and after treatment was statistically significant(P<0.05).The average PR+NP before the treatment in the control group was 3.2.(37.87±12.95)%.After treatment,the mean PR+NP was(41.44±14.11)%.There was no significant difference between before and after(P>0.05).3.3 The average PR(24.03±9.35)% in the experimental group a fter treatment,and the average PR in the control group(22.00±12.11)% after treatment,but the difference was not statistically significant(P>0.05).The average PR+NP was(44.09±13.44)% in the experimental group after treatment,while the average PR+NP was(41.44±14.11)% in the control group after treatment.There was no significant difference in the total sperm vitality between the two groups after treatment(P> 0.05).3.4 The two groups of patients completed the test after the TCM syndrome score,the te st group overall efficiency of 94.44%,the overall efficiency of the control group was 79.49%.Conclusion: 1.The combination of intensive sperm and moxibustion can significantly increase the percentage of sperm and total sperm motility in patients with a sthenozoospermia.2.The combination of Qiangjing Tablets and moxibustion can significantly improve the TCM syndrome score of patients with weak azoospermia.3.The use of moxibustion has no obvious side effects and adverse reactions,and it is safe.
Keywords/Search Tags:benefiting the governor, regulating yin and Yang, moxibustion, kidney yang deficiency, Asthenospermia, clinical research
PDF Full Text Request
Related items